FIG 2.

In vitro drug susceptibilities of Plasmodium falciparum isolates collected in the year 2015 from Brikama determined by flow cytometry (ACCURI) and IVART for standard inhibitory drug concentrations (IC₅₀) and RSA against dihydroartemisinin. The logIC₅₀ for each isolate is shown for quinolines (chloroquine [CQ], quinine [QN], AMD, and LUM) (a), SP drugs sulfadoxine (SD) and pyrimethamine (PYR) (b), and artemisinin derivatives DHA and ARM (c). (d) RSA. The percentage of infected cells with parasite growth after DHA treatment of ring stages for each isolate is shown. Broken red lines are the median value of the isolates for each assay.